Rite Aid defeats MedImpact in $200 million Elixir sale dispute By Reuters
Written by Dietrich Knuth NEW YORK (Reuters) - MedImpact's attempt to recover about $200 million in connection with its purchase of Rite Aid's (NYSE:) pharmacy benefits unit failed after a judge ruled on Monday that it assumed Elixir's…
